Last year, when researchers in Cambridge, Mass., announced that they had found a gene strongly linked to a higher risk of schizophrenia, the news media reacted with over-zealous enthusiasm. A “landmark study,” declared both the New York Times and the Washington Post. “Ground-breaking,” trumpeted CNN. Even the Economist dropped its normal reserve: “Genetics throws open a window on a perplexing disorder.”